Latest news

Insights

5 Life Sciences Trends Defining the Next Decade of Healthcare Innovation

Executive Summary The life sciences industry is entering a transformative decade driven by artificial intelligence, precision medicine, digital health infrastructure,...
Insights

Can AI Reduce Drug Development Costs Without Increasing Risk?

Executive Summary Yes—AI can reduce drug development costs without proportionally increasing risk, but only when deployed within structured scientific, regulatory,...
Clinical

Inhibrx Reports Higher Response Rate for INBRX-106 and Keytruda in Midphase Head and Neck Cancer Trial

Inhibrx Biosciences reported interim data from the phase 2 portion of its HexAgon study showing a higher objective response...
Regulatory

Biogen and Eisai were slapped with a three-month delay in beginning SubQ Alzheimer’s treatment

SubQ Biogen and Eisai could be forced to wait another three months to hear the verdict from the FDA...
Insights

How Are Life Sciences Companies Reducing Environmental Impact Across Supply Chains?

Executive Summary Life sciences companies are reducing environmental impact across...
Insights

How Is Generative AI Changing Drug Discovery in 2026?

Executive Summary Generative AI is fundamentally reshaping drug discovery in...
Insights

The Rise of AI-Powered Clinical Trials: What Pharma Leaders Need to Know

Executive Summary AI-powered clinical trials are becoming a core operational strategy across pharma and biotech in 2026. Artificial intelligence is...
Insights

Why Biotech Companies Are Rebuilding Their Data Strategies for AI

Executive Summary Biotech companies are rebuilding their data strategies in 2026 because legacy infrastructure is no longer sufficient to support...
Regulatory

FDA chastises Alnylam for its efficacy claims on the Amvuttra website

The FDA's letter and warning to Alnylam (PDF) is untitled and accuses the biotech of providing open-label data that...
Clinical

CellCentric Raises $220 Million Series D to Advance Inobrodib and Launch Phase 3 Myeloma Trial

CellCentric has secured $220 million in a Series D...
Commercial

Bayer Expands Opthalmology Pipeline With $2.4B Perfuse Acquisition

Bayer has agreed to acquire Perfuse Therapeutics in a...
Clinical

Entrada Therapeutics Reports 2.36% Dystrophin Increase in Early DMD Trial Data

Entrada Therapeutics reported early Phase 1/2 results for its Duchenne muscular dystrophy (DMD) candidate ENTR-601-44, showing a 2.36% increase...
Manufacturing

Lilly Adds $4.5 Billion to Indiana Manufacturing Expansion, Total U.S. Commitments Exceed $50 Billion

Eli Lilly has announced an additional $4.5 billion investment to expand two of its three manufacturing facilities under development...
Commercial

Madrigal Licenses ARO-PNPLA3 from Arrowhead in Deal Worth Up to $1 Billion

Madrigal Pharmaceuticals has entered into a licensing agreement with Arrowhead Pharmaceuticals to obtain rights to ARO-PNPLA3, an RNA interference...
Commercial

Bayer Expands Opthalmology Pipeline With $2.4B Perfuse Acquisition

Bayer has agreed to acquire Perfuse Therapeutics in a...
Editorial Team -
Commercial

Evommune Seeks IPO to Advance Work on Immune Drug

It looks like biotech IPOs are about to become...
Commercial

Gilead Explores Triple-Target T-Cell Engagers in over $1.5B Merus Partnership

Bispecific T-cell engagers are gaining prominence in oncology, yet...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...
Editorial Team -

Regulatory

Insights

Can AI Reduce Drug Development Costs Without Increasing Risk?

Executive Summary Yes—AI can reduce drug development costs without proportionally...
Clinical

Inhibrx Reports Higher Response Rate for INBRX-106 and Keytruda in Midphase Head and Neck Cancer Trial

Inhibrx Biosciences reported interim data from the phase 2...
Regulatory

Biogen and Eisai were slapped with a three-month delay in beginning SubQ Alzheimer’s treatment

SubQ Biogen and Eisai could be forced to wait...
Insights

Top 10 Skills Every Life Sciences Professional Needs in 2026

Executive Summary The life sciences industry in 2026 is undergoing...

Research & Development

Market Access

Manufacturing

Johnson & Johnson Agrees to MFN Drug Pricing and Expands U.S. Manufacturing Plans

Five months ago, Johnson & Johnson also announced plans...
Manufacturing

U.S. Biopharma Companies Advance Over $370B in Manufacturing and R&D Investments

Major drugmakers have announced more than $370 billion in...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

5 Life Sciences Trends Defining the Next Decade of Healthcare Innovation

Executive Summary The life sciences industry is entering a transformative...
Editorial Team -